MG
AXNX

Michael Gelband’s Axonics, Inc. Common Stock AXNX Stock Holding History

Michael Gelband’s Portfolio AXNX Stock Details AXNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-47,700
Closed -$2.38M – 2699
2020
Q4 		$2.38M Sell
47,700
-2,300
-5% -$108K 0.02% 472
2020
Q3 		$2.56M Buy
+50,000
New +$2.09M 0.05% 328

Other funds holding AXNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Axa
Axa Paris, France $91.9M AUM 27.41% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Michael Gelband's AXNX Position: Q4 2023 in Review

Michael Gelband sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2023, closing a stake of 10,298 shares — an estimated $578K sold.

Michael Gelband first reported a position in AXNX in Q2 2019 and held it in 8 quarters. The position peaked at $2.41M in Q1 2023. 230 funds tracked by Wall St. Rank hold AXNX as of Q4 2023.

  • Michael Gelband reported no remaining Axonics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Michael Gelband sold 10,298 Axonics, Inc. Common Stock shares in Q4 2023, an estimated $578K.
  • Michael Gelband first reported a position in Axonics, Inc. Common Stock in Q2 2019 and held it in 8 quarters.
  • Michael Gelband's Axonics, Inc. Common Stock position peaked at $2.41M in Q1 2023.
  • 230 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2023.

Based on ExodusPoint Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.